Company: AGTX
Filing Date: 2025-07-16
Form Type: 10-K
Source: 0001477932-25-005077
Chunk: 79

Company: Agentix Corp.
Filing Date: 2025-07-16
Form: 10-K
Item: Item 1A
Chunk 79
---
 Prepayments and other current assets  4,041   117,609 Accrued expenses, accounts payable and accounts payable-related party  437,929   63,040 Net Cash Provided by (Used in) Operating Activities  (125,078 )  (110,429 )         Cash Flows from Investing Activities  -   -          Cash Flows from Financing Activities        Proceeds from issuance of debt  100,000   163,000 Principal payments of debt  -   (70,000) Net Cash Provided by Financing Activities  100,000   93,000          Effects of Foreign Exchange Rate Changes on Cash  23,020   11,595 Net Change in Cash  (2,058 )  (5,834 )         Cash - beginning of reporting period  6,535   12,369          Cash - end of reporting period $4,477  $6,535          Supplemental disclosure of cash flow information:        Interest paid $-  $3,223 Income tax paid $-  $- 

See accompanying notes to the consolidated financial statements.

 F-6Table of Contents

Note 1 - Organization and Basis of Presentation Description of the Company FairWind Energy, Inc. (the "Company") was incorporated on April 18, 2013 under the laws of the State of Nevada. Effective June 17, 2019, the Company changed its name to Agentix Corp. In March 2022, the Company changed its fiscal year end from August to March. The Company is a clinical-stage biotechnology company developing therapeutic agents for the treatment of metabolic disease like Type 2 diabetes mellitus, obesity, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Going Concern The Company’s consolidated financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in the consolidated financial statements, the Company had an accumulated deficit on March 31, 2025, negative cash from operations for the years ended March 31, 2025 and 2024, and a net loss for the year ended March 31, 202